VIRX News and Press, Viracta Therapeutics Inc. From 03/11/21

Viracta Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference PR Newswire SAN DIEGO , March 11, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc.  (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, ...

Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team Stephen Rubino, Ph.D., MBA and Barry J. Simon, M.D. appointed to the Board of Directors Cheryl A. Madsen, RAC appointed as Senior Vice President, Regulator...

Viracta Therapeutics to Participate at H.C. Wainwright Global Life Sciences Conference PR Newswire SAN DIEGO , March 3, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today...